Is IVME or EQR a better dividend investment in 2026?

IVME currently yields 285714.29% with a 5% 5-year dividend growth rate. EQR yields 5.87% with 5% growth. The better choice depends on your goal: IVME offers higher current income.

What is the dividend yield difference between IVME and EQR?

IVME has a forward dividend yield of 285714.29% ($2.00/share annually). EQR yields 5.87% ($3.47/share annually). The yield gap is 285708.42 percentage points.

Home › Compare › IVME vs EQR

IVME vs EQR: Dividend Comparison 2026

IVME yields 285714.29% · EQR yields 5.87%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IVME wins by $1.734986541242196e+31M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IVME

● Live price

285714.29%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.734986541242196e+31M

Annual income

$17,337,928,197,276,910,000,000,000,000,000,000,000.00

Full IVME calculator →

EQR

● Live price

5.87%

Share price

$59.15

Annual div

$3.47

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47.8K

Annual income

$5,475.61

Full EQR calculator →

Portfolio growth — IVME vs EQR

📍 IVME pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IVME	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IVME + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IVME pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVME

Annual income on $10K today (after 15% tax)

$24,285,714.29/yr

After 10yr DRIP, annual income (after tax)

$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr

EQR

Annual income on $10K today (after 15% tax)

$499.01/yr

After 10yr DRIP, annual income (after tax)

$4,654.27/yr

At 15% tax rate, IVME beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVME + EQR for your $10,000?

IVME: 50%EQR: 50%

100% EQR50/50100% IVME

Portfolio after 10yr

$8.67493270621098e+30M

Annual income

$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr

Blended yield

99.93%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

IVME

No analyst data

Altman Z

-205.3

Piotroski

2/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+18.9% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVME buys

EQR buys

No recent congressional trades found for IVME or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIVMEEQR

Forward yield	285714.29% ✓	5.87%
Annual dividend / share	$2.00	$3.47 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$1.734986541242196e+31M	$47.8K ✓
Annual income after 10y	$17,337,928,197,276,910,000,000,000,000,000,000,000.00 ✓	$5,475.61
Total dividends collected	$1.734908400352195e+31M	$23.0K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: IVME vs EQR ($10,000, DRIP)

Year	IVME Portfolio	IVME Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$28,582,129	$28,571,428.57	$11,380	$679.82	+$28.57M → IVME
2	$76,351,353,429	$76,320,770,551.21	$13,014	$837.25	+$76351.34M → IVME
3	$190,619,493,207,524	$190,537,797,259,355.30	$14,961	$1,036.20	+$190619493.19M → IVME
4	$444,781,927,427,195,200	$444,577,964,569,463,100.00	$17,297	$1,289.22	+$444781927427.18M → IVME
5	$969,967,353,346,567,200,000	$969,491,436,684,220,000,000.00	$20,121	$1,613.15	+$969967353346567.13M → IVME
6	$1,976,961,629,315,093,000,000,000	$1,975,923,764,247,012,300,000,000.00	$23,561	$2,030.84	+$1976961629315092992.00M → IVME
7	$3,765,923,944,594,039,000,000,000,000	$3,763,808,595,650,671,000,000,000,000.00	$27,783	$2,573.54	+$3.765923944594039e+21M → IVME
8	$6,704,681,437,057,684,000,000,000,000,000	$6,700,651,898,436,968,000,000,000,000,000.00	$33,013	$3,284.39	+$6.704681437057683e+24M → IVME
9	$11,156,275,836,497,016,000,000,000,000,000,000	$11,149,101,827,359,364,000,000,000,000,000,000.00	$39,547	$4,223.51	+$1.1156275836497015e+28M → IVME
10	$17,349,865,412,421,960,000,000,000,000,000,000,000	$17,337,928,197,276,910,000,000,000,000,000,000,000.00	$47,791	$5,475.61	+$1.734986541242196e+31M → IVME

IVME vs EQR: Complete Analysis 2026

IVME — Stock

In Veritas Medical Diagnostics, Inc., a development stage company, engages in the research and development of medical devices with `near-patient' testing applications. Its primary product includes prothrombin monitor, which is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke. The company's other products under development include predictor of labor onset, a consumer device for maternity planning; biomarker monitor for the measurement of a number of biomarkers, including heart attack, HIV, cholesterol, and cancer; blood glucose monitor, a noninvasive glucose concentration continuous bulk measuring device measurement; digital scanning machine, a noninvasive alternative to 2D X-ray scanning; osteoporosis detection and monitoring device, an instant display of bonemineral density for osteoporosis patients; and hand held digital strip reader for immunoassay applications. It was formerly known as In Vivo Medical Diagnostics, Inc. and changed its name to In Veritas Medical Diagnostics, Inc. in 2005. The company is based in Inverness, the United Kingdom.

Full IVME Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this IVME vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVME vs SCHD IVME vs JEPI IVME vs O IVME vs KO IVME vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.